---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-24-000224"
form_type: "8-K/A"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T17:52:13.476900+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Recursion issues 102.3M shares to close Exscientia acquisition

## Summary
- 102,298,808 shares of Class A common stock issuable to Exscientia shareholders and option/RSU holders.
- Shares issued in exchange for Exscientia ordinary shares and canceled equity awards under the Transaction Agreement.
- Issuance exempt from registration under Securities Act Section 3(a)(10).
- Transaction closed on November 20, 2024; this Amendment provides final share count.

## SEC filing metadata
- accession: 0001601830-24-000224
- form_type: 8-K/A
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000224/0001601830-24-000224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000224/rxrx-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-24-000224
- JSON: https://secwatch.observer/filing/0001601830-24-000224.json
- Plain text: https://secwatch.observer/filing/0001601830-24-000224.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.